首页 | 本学科首页   官方微博 | 高级检索  
     

丙酮酸激酶M2抑制剂研究进展
引用本文:王晓娜,赵林.丙酮酸激酶M2抑制剂研究进展[J].山东轻工业学院学报,2014(2):43-46.
作者姓名:王晓娜  赵林
作者单位:齐鲁工业大学山东省微生物工程重点实验室,山东济南250353
基金项目:省级博士后创新基金会(201203006); 山东省科技支撑计划项目(2012GSF12107)
摘    要:在近几年中癌症严重危害人们的生命及健康,对于癌症的治疗费用一般家庭无法承受,对于癌症的诊断和治疗已经成为研究的热点。丙酮酸激酶M2(PKM2)是肿瘤细胞好氧糖酵解的一个限速酶同时在癌细胞代谢和生长中占有重要地位。研究丙酮酸激酶M2型抑制剂对于癌症的治疗具有重要的意义。

关 键 词:丙酮酸激酶M2  肿瘤细胞  抑制剂

The study of inhibitor of pyruvate kinase M2
WANG Xiao-na,ZHAO Lin.The study of inhibitor of pyruvate kinase M2[J].Journal of Shandong Institute of Light Industry(Natural Science Edition),2014(2):43-46.
Authors:WANG Xiao-na  ZHAO Lin
Affiliation:( Shandong Provincial Key Laboratory of Microbial Engineering, Qilu University of Technology ,Jinan 250353, China)
Abstract:In recent years cancer has caused serious damage to people's lives and health,because people can't afford cancer treatment costs in a common family. The diagnosis and treatment for cancer has become the research hot spot. Pyruvate kinase M2( PKM2) is a tumor cell aerobic glycolysis a speed limit of enzymes in cancer cells,at the same time it occupies an important place in the metabolism and growth.The study of pyruvate kinase type M2 inhibitors for the treatment of cancer has important significance.
Keywords:Pyruvate kinase M2  tumour cell  inhibitor
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号